DZ2110A1 - Compositions pour inhiber l'agégation des plaquettes. - Google Patents

Compositions pour inhiber l'agégation des plaquettes.

Info

Publication number
DZ2110A1
DZ2110A1 DZ960154A DZ960154A DZ2110A1 DZ 2110 A1 DZ2110 A1 DZ 2110A1 DZ 960154 A DZ960154 A DZ 960154A DZ 960154 A DZ960154 A DZ 960154A DZ 2110 A1 DZ2110 A1 DZ 2110A1
Authority
DZ
Algeria
Prior art keywords
platelets
aggregation
inhibiting
compositions
tonicity
Prior art date
Application number
DZ960154A
Other languages
English (en)
Inventor
Karl M Gelotte
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603721.3A external-priority patent/GB9603721D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DZ2110A1 publication Critical patent/DZ2110A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DZ960154A 1995-10-27 1996-10-26 Compositions pour inhiber l'agégation des plaquettes. DZ2110A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US590795P 1995-10-27 1995-10-27
GBGB9603721.3A GB9603721D0 (en) 1996-02-22 1996-02-22 Composition for inhibiting platelet aggregation

Publications (1)

Publication Number Publication Date
DZ2110A1 true DZ2110A1 (fr) 2002-07-22

Family

ID=26308777

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ960154A DZ2110A1 (fr) 1995-10-27 1996-10-26 Compositions pour inhiber l'agégation des plaquettes.

Country Status (35)

Country Link
EP (1) EP0859634B1 (fr)
JP (1) JP3452367B2 (fr)
KR (1) KR100362799B1 (fr)
CN (1) CN1158107C (fr)
AT (1) ATE213648T1 (fr)
AU (1) AU712755B2 (fr)
BG (1) BG63623B1 (fr)
BR (1) BR9610878A (fr)
CA (1) CA2234364C (fr)
CO (1) CO4770960A1 (fr)
CY (1) CY2292B1 (fr)
CZ (1) CZ290381B6 (fr)
DE (1) DE69619540T2 (fr)
DK (1) DK0859634T3 (fr)
DZ (1) DZ2110A1 (fr)
EA (1) EA000628B1 (fr)
EE (1) EE03518B1 (fr)
ES (1) ES2171749T3 (fr)
HK (1) HK1017846A1 (fr)
HU (1) HU228757B1 (fr)
IL (1) IL123790A (fr)
IS (1) IS1948B (fr)
MX (1) MX9803275A (fr)
MY (1) MY116837A (fr)
NO (1) NO324415B1 (fr)
NZ (1) NZ323134A (fr)
PL (1) PL185744B1 (fr)
PT (1) PT859634E (fr)
SA (1) SA96170527B1 (fr)
SI (1) SI0859634T1 (fr)
SK (1) SK282353B6 (fr)
TR (1) TR199800716T2 (fr)
TW (1) TW385248B (fr)
UA (1) UA45423C2 (fr)
WO (1) WO1997015328A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ633900A0 (en) 2000-03-20 2000-04-15 Jurox Pty Ltd Anaesthetic composition
CN1322863C (zh) * 2004-10-29 2007-06-27 武汉远大制药集团股份有限公司 一种抑制血小板凝聚的注射液及其制备方法
CN100386079C (zh) * 2005-03-24 2008-05-07 武汉远大制药集团股份有限公司 一种抑制血小板凝聚的注射用粉针及其制备方法
CN100367961C (zh) * 2005-09-30 2008-02-13 天津南开允公医药科技有限公司 盐酸替罗非班冻干粉针注射剂及其制备方法
CN102125519B (zh) * 2011-02-28 2012-07-11 正大青春宝药业有限公司 稳定的盐酸替罗非班注射液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931441A (en) * 1988-11-09 1990-06-05 Luitpold Pharmaceuticals, Inc. Stabilized aqueous leucovorin calcium compositions
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
PT859634E (pt) 2002-07-31
DE69619540T2 (de) 2002-08-22
EP0859634B1 (fr) 2002-02-27
MY116837A (en) 2004-04-30
ATE213648T1 (de) 2002-03-15
NO981869L (no) 1998-04-24
PL326419A1 (en) 1998-09-14
AU712755B2 (en) 1999-11-18
WO1997015328A1 (fr) 1997-05-01
PL185744B1 (pl) 2003-07-31
KR19990067020A (ko) 1999-08-16
SI0859634T1 (en) 2002-04-30
DK0859634T3 (da) 2002-03-25
JP3452367B2 (ja) 2003-09-29
TR199800716T2 (xx) 1998-07-21
CZ290381B6 (cs) 2002-07-17
IL123790A (en) 2001-11-25
JPH10512296A (ja) 1998-11-24
AU7718996A (en) 1997-05-15
CN1158107C (zh) 2004-07-21
NO981869D0 (no) 1998-04-24
IL123790A0 (en) 1998-10-30
SK51298A3 (en) 1998-12-02
DE69619540D1 (de) 2002-04-04
HU228757B1 (en) 2013-05-28
CY2292B1 (en) 2003-07-04
CN1200676A (zh) 1998-12-02
EE03518B1 (et) 2001-10-15
BR9610878A (pt) 1999-07-13
SA96170527B1 (ar) 2005-12-21
MX9803275A (es) 1998-09-30
BG63623B1 (bg) 2002-07-31
ES2171749T3 (es) 2002-09-16
CO4770960A1 (es) 1999-04-30
CA2234364A1 (fr) 1997-05-01
UA45423C2 (uk) 2002-04-15
CZ127898A3 (cs) 1998-10-14
EE9800134A (et) 1998-10-15
NZ323134A (en) 1999-11-29
SK282353B6 (sk) 2002-01-07
HK1017846A1 (en) 1999-12-03
CA2234364C (fr) 2000-02-08
IS4699A (is) 1998-03-24
HUP9902521A2 (hu) 1999-12-28
KR100362799B1 (ko) 2003-07-16
IS1948B (is) 2004-10-13
HUP9902521A3 (en) 2000-01-28
NO324415B1 (no) 2007-10-08
EA199800336A1 (ru) 1998-10-29
BG102405A (en) 1999-08-31
TW385248B (en) 2000-03-21
EP0859634A1 (fr) 1998-08-26
EA000628B1 (ru) 1999-12-29

Similar Documents

Publication Publication Date Title
HK1075197A1 (en) New composition containing taxane derivatives as major component
KR920008024A (ko) 퀴놀린 유도체
EP0223515A3 (fr) Compositions orales comprenant des salicylamides et des sels de zinc pour l'inhibition synergique de la plaque dentaire
GB1418822A (en) Imidazo-and pyrimido-2,1-b-quinazolin-2-ones and a process for the preparation thereof
ES482782A1 (es) Un procedimiento para la preparacion de derivados de imida- zol
ES429221A1 (es) Procedimiento para la preparacion de nuevas amidas de aci- dos n-(1-omega-fenilalcohil)-piperidil-4) - n-(alfa-piridil)-carboxilicos.
DE3176274D1 (en) New cephem compounds and processes for preparation thereof
DZ2110A1 (fr) Compositions pour inhiber l'agégation des plaquettes.
DE3362504D1 (en) 1-carboxyalkanoylindoline-2-carboxylic-acid esters, their preparation, pharmaceutical compositions containing them, and their therapeutic use
IE43139L (en) Bis-biguanide compounds
GB1161349A (en) New Capillary Product
HUP9800631A2 (hu) 4-Amino-tetrahidrobenzizoxazol- és 4-amino-tetrahidrobenzizotiazol-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk gyógyszerkészítmények előállítására
ES8604118A1 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo n-carbamiloxi sustituido
NZ246598A (en) Trazodone derivatives; compounds and preparation, pharmaceutical compositions; intermediate compounds
HK1011989A1 (en) Cyclohexane derivatives processes for their preparation and their use as glucose-6- phosphatase inhibitors
GB1413454A (en) 4-alkoxyalkyleneoxy-5-benzylpyrimidines their preparation and pharmaceutical compositions thereof
ES8302719A1 (es) Un procedimiento para preparar compuestos de cefem
ES8507524A1 (es) Un procedimiento para preparar derivados de tropona
ES8300709A1 (es) Un metodo para la preparacion de derivados de pirazolidinona
KR950000638A (ko) 3, 4-디히드록시칼콘 유도체
IL145076A0 (en) Novel intermediate for the synthesis of prostaglandins
GB1384441A (en) Benzomorphan derivatives
GB1414938A (en) 6-aza-1,2-dihydro-3h-1,4-benzodiazepines
GB1488826A (en) Anti-snore composition